DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

SUDARSHAN vs VITAL: Stock Comparison

SUDARSHAN PHARMA IND vs VITAL CHEMTECHUpdated 13 Nov 26, 4:08 PM ISTNSE & company filings

SUDARSHAN PHARMA IND shows a lower P/E, while VITAL CHEMTECH shows a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

SUDARSHAN leads 3; VITAL leads 3 of 9

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

SUDARSHANVITAL

Valuation lens

What price are you paying?

Market CapContext only
₹0 Cr
—
P/E RatioSUDARSHAN has the lower reading
28.27x ✓
32.07x
P/B RatioVITAL has the lower reading
4.11x
1.4x ✓
EPSVITAL has the higher reading
₹0.32
₹0.98 ✓
Book ValueContext only
₹6.14
₹41.74
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

P/E Ratio
SUDARSHAN has a lower P/E
28.27x vs 32.07x
P/B Ratio
VITAL has a lower P/B
1.4x vs 4.11x
EPS
VITAL has higher earnings per share
₹0.98 vs ₹0.32
Qtr Sales Growth
SUDARSHAN has stronger quarterly sales growth
24.4% vs -2.36%
Qtr Profit Growth
SUDARSHAN has stronger quarterly profit growth
38.7% vs -1.73%
Net Margin
VITAL has a higher net margin
0.81% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Price

MetricSUDARSHANVITAL
Live Price₹32.71₹51
Day Change0.03%-1.92%
Volume92,9855,097
52-Week High₹39.3₹69.4
52-Week Low₹31.01₹35.4
Distance from 52W High-16.77%-26.51%

Valuation

MetricSUDARSHANVITAL
Market Cap₹0 Cr—
P/E Ratio28.27x32.07x
P/B Ratio4.11x1.4x
EPS₹0.32₹0.98
Book Value₹6.14₹41.74
Dividend Yield0%0%

Growth

MetricSUDARSHANVITAL
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth24.4%-2.36%
Qtr Profit Growth38.7%-1.73%

Profitability & Leverage

MetricSUDARSHANVITAL
ROE—7.95%
ROCE—8.3%
Net Margin0%0.81%
Operating Margin—11.38%
Debt to Equity—0.1x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricSUDARSHANVITAL
Promoter Holding57.81%▼ 1.12 pp73.43%
FII Holding21.95%▲ 2.57 pp1.62%
DII Holding0%0.25%
Public Holding20.19%▼ 1.45 pp24.7%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: SUDARSHAN PHARMA IND and VITAL CHEMTECH.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.